Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27073034)

Published in Int Orthop on April 12, 2016

Authors

Michael Monfett1, Julian Harrison1, Kwadwo Boachie-Adjei1, Gregory Lutz2

Author Affiliations

1: Department of Physiatry, Hospital for Special Surgery, 429 E 75th Street, 3rd Floor, New York, NY, 10021, USA.
2: Department of Physiatry, Hospital for Special Surgery, 429 E 75th Street, 3rd Floor, New York, NY, 10021, USA. lutzg@hss.edu.

Associated clinical trials:

Intra-articular Corticosteroid Injections to Platelet Rich Plasma (PRP) for Cervical Facetogenic Pain (PRICE) | NCT04392999

Articles cited by this

Epidemiological features of chronic low-back pain. Lancet (1999) 10.06

Regulation of wound healing by growth factors and cytokines. Physiol Rev (2003) 9.82

Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost (2004) 4.26

The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther (2005) 3.47

An overview of the incidences and costs of low back pain. Orthop Clin North Am (1991) 3.13

Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician (2007) 3.05

Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am (2006) 2.71

The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine (Phila Pa 1976) (1995) 2.53

Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976) (2005) 2.34

Disability resulting from occupational low back pain. Part I: What do we know about primary prevention? A review of the scientific evidence on prevention before disability begins. Spine (Phila Pa 1976) (1996) 1.97

Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford) (2008) 1.75

Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol (2008) 1.50

Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg (1993) 1.29

Twelve-month follow-up of a controlled trial of intradiscal thermal anuloplasty for back pain due to internal disc disruption. Spine (Phila Pa 1976) (2000) 1.22

Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol (2006) 1.20

Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng (2007) 1.16

Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma. Biomaterials (2009) 1.14

Nucleus pulposus replacement: basic science and indications for clinical use. Spine (Phila Pa 1976) (2005) 1.13

Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine (Phila Pa 1976) (2006) 1.08

Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther (2012) 1.05

Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A (2009) 1.02

Autoimmunity in intervertebral disc herniation: from bench to bedside. Expert Opin Ther Targets (2013) 1.02

Reoperation after lumbar disc surgery in two hundred and seven patients. Int Orthop (2013) 1.01

Two-year follow-up of a controlled trial of intradiscal electrothermal anuloplasty for chronic low back pain resulting from internal disc disruption. Spine J (2003) 0.99

Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage. J Clin Invest (1994) 0.97

Establishment of a promising human nucleus pulposus cell line for intervertebral disc tissue engineering. Tissue Eng Part C Methods (2013) 0.88

Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study. PM R (2015) 0.87

Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1. J Orthop Res (2013) 0.86

Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J (2011) 0.86

Growth factors and platelet-rich plasma: promising biological strategies for early intervertebral disc degeneration. Int Orthop (2015) 0.83

Intradiscal electrothermal therapy (IDET) for treatment of chronic lumbar discogenic pain: a minimum 2-year clinical outcome study. Pain Physician (2003) 0.83

A prospective outcomes study of patients undergoing intradiscal electrothermy (IDET) for chronic low back pain. Pain Physician (2002) 0.81

Intradiscal electrothermal therapy (IDET) for chronic low back pain in active-duty soldiers: 2-year follow-up. Spine J (2003) 0.78

Platelet-rich plasma induces annulus fibrosus cell proliferation and matrix production. Eur Spine J (2014) 0.78

Gradient composite materials for artificial intervertebral discs. Acta Bioeng Biomech (2014) 0.77

Study design: in vitro and in vivo assessment of bone morphogenic protein 2 combined with platelet-rich plasma on treatment of disc degeneration. Int Orthop (2015) 0.77

Predictors of pain and disability outcomes in one thousand, one hundred and eight patients who underwent lumbar discectomy surgery. Int Orthop (2015) 0.77

Inhibitory effects of platelet-rich plasma on intervertebral disc degeneration: a preclinical study in a rabbit model. Med Sci Monit (2015) 0.77

Detrimental effects of discectomy on intervertebral disc biology can be decelerated by growth factor treatment during surgery: a large animal organ culture model. Spine J (2014) 0.77